Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Effect of aspirin resistance with dyslipidemia against VerifyNOW® measurement in Bethesda hospital Yogyakarta

Jurnal kedokteran dan kesehatan Indonesia · Vol. 7 No. 2 (2015) · pp. 41–45

DOI
10.20885/jkki.vol7.iss2.art2
ISSN
2085-4145, 2527-2950
Published
2015-09-20
Publisher
Islamic University of Indonesia
Language
en
License
creativecommons.org/licenses/by/4.0/

Abstract

Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases are found occuring of aspirin resistance. Objective: This study was to examine the effect of dyslipidemia on the risk of antiplatelet resistance with VerifyNOW ® at Bethesda Hospital Yogyakarta. Method: This research was observational analysis using a nested casecontrol study design. The subjects were ischemic stroke patients who underwent tests of platelet function by VerifyNOW® (Accumetrics, San Diego, CA, USA). The Case group was ischemic stroke patients who has history of aspirin resistance. The control group was ischemic stroke patients who response on aspirin therapy. Both groups were analyzed and compared to the state of dyslipidemia. Results: Bivariate analysis on the incidence of aspirin resistance indicate that dyslipidemia had OR = 0.979 (95% CI; 0.378 to 2.531), p = 0.572. Hypercholesterolemia had OR = 0,909 (CI 95%; 0,377-2,190) p = 0,500; hypertrigliceride had OR = 0,838 (CI 95%; 0,331-2,119) p = 0,409; abnormal HDL had OR = 1,468 (CI 95% 0,564-3,817) p = 0,238; abnormal LDL had OR = 0,937 (CI 95% 0,374-2,345) p = 0,500. Patient factors such as age >55 years (p = 0.168) and female gender (p = 0.226) showed a nonsignificant results. Conclusion: Ischemic stroke patients at Bethesda Hospital Yogyakarta who had dyslipidemia were not evident to have a greater risk of aspirin resistance than ischemic stroke patients who did not undergo dyslipidemia.

Keywords

Collaboration network of the authors

24 authors · 45 co-authorship links · 24 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Duta Wacana Christian University
  • Universitas Gadjah Mada
  • Bethesda Hospital
  • Universitas Ahmad Dahlan
  • State University of Semarang
  • Muhammadiyah University of Surakarta
  • Islamic University of Indonesia
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Sugianto SugiantoState University of Semarang2
Esdras Ardi PramuditaDuta Wacana Christian University2
Rosa De Lima Renita SanyasiAffiliation unknown2
Andre Dharmawan WijonoAffiliation unknown1
Renita, Rosa De LimaAffiliation unknown1
Hanshel Everad NathanaelDuta Wacana Christian University1
EM SutrisnaMuhammadiyah University of Surakarta1
Iwan DwiprahastoUniversitas Gadjah Mada1
Laksmi AsantiBethesda Hospital1
Kriswanto WidyoBethesda Hospital1
Lucas MelialaUniversitas Gadjah Mada1
Sri SutarniAffiliation unknown1
Fransiska Theresia Meivy BabangDuta Wacana Christian University1
Ari WibowoIndonesian Coffee and Cocoa Research Institute1
Dwi Aris Agung NugrahaningsihUniversitas Gadjah Mada1
Mustofa MustofaUniversitas Gadjah Mada1
Akhmad Kharis NugrohoUniversitas Gadjah Mada1
Dimas Adhi PradanaIslamic University of Indonesia1
Daniel Mahendra KrisnaDuta Wacana Christian University1
HariatmokoBethesda Hospital1
Aditya BatlajeryDuta Wacana Christian University1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210214198, first harvested 20 Nov 2026, last seen 20 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Effect of aspirin resistance with dyslipidemia against VerifyNOW® measurement in Bethesda hospital Yogyakarta</dc:title><dc:creator>Hardi Astuti Witasari</dc:creator><dc:creator>Rizaldy Taslim Pinzon</dc:creator><dc:creator>Erna Kristin</dc:creator><dc:subject>aspirin resistance</dc:subject><dc:subject>dyslipidemia</dc:subject><dc:subject>ischemic stroke</dc:subject><dc:subject>antiplatelet therapy</dc:subject><dc:subject>hypercholesterolemia</dc:subject><dc:subject>hypertriglyceridemia</dc:subject><dc:subject>ischemic stroke risk factors</dc:subject><dc:description xml:lang="en">Background: Aspirin is first line drug of choice to prevent ischemic stroke. However, some cases are found occuring of aspirin resistance. Objective: This study was to examine the effect of dyslipidemia on the risk of antiplatelet resistance with VerifyNOW ® at Bethesda Hospital Yogyakarta. Method: This research was observational analysis using a nested casecontrol study design. The subjects were ischemic stroke patients who underwent tests of platelet function by VerifyNOW® (Accumetrics, San Diego, CA, USA). The Case group was ischemic stroke patients who has history of aspirin resistance. The control group was ischemic stroke patients who response on aspirin therapy. Both groups were analyzed and compared to the state of dyslipidemia. Results: Bivariate analysis on the incidence of aspirin resistance indicate that dyslipidemia had OR = 0.979 (95% CI; 0.378 to 2.531), p = 0.572. Hypercholesterolemia had OR = 0,909 (CI 95%; 0,377-2,190) p = 0,500; hypertrigliceride had OR = 0,838 (CI 95%; 0,331-2,119) p = 0,409; abnormal HDL had OR = 1,468 (CI 95% 0,564-3,817) p = 0,238; abnormal LDL had OR = 0,937 (CI 95% 0,374-2,345) p = 0,500. Patient factors such as age &gt;55 years (p = 0.168) and female gender (p = 0.226) showed a nonsignificant results. Conclusion: Ischemic stroke patients at Bethesda Hospital Yogyakarta who had dyslipidemia were not evident to have a greater risk of aspirin resistance than ischemic stroke patients who did not undergo dyslipidemia.</dc:description><dc:publisher>Islamic University of Indonesia</dc:publisher><dc:date>2015-09-20</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20885/jkki.vol7.iss2.art2</dc:identifier><dc:identifier>10.20885/jkki.vol7.iss2.art2</dc:identifier><dc:source>Jurnal kedokteran dan kesehatan Indonesia; Vol 7 No 2 (2015); 41-45</dc:source><dc:source>2085-4145</dc:source><dc:source>2527-2950</dc:source><dc:language>en</dc:language><dc:relation>https://journal.uii.ac.id/JKKI/article/view/4500/3970</dc:relation><dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights></oai_dc:dc>